Global Gene Therapies for Cancer Treatment market will register a 67.3% CAGR in terms of revenue, the market size will reach USD 25.3 Billion by 2024, from USD 1.94 Billion in 2019.
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.
The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.
ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.
According to this study, over the next five years the Gene Therapies for Cancer Treatment market will register a 67.3% CAGR in terms of revenue, the global market size will reach US$ 25300 million by 2024, from US$ 1940 million in 2019. In particular, this report presents the global revenue market share of key companies in Gene Therapies for Cancer Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Gene Therapies for Cancer Treatment market by product type, application, key companies and key regions.
This study considers the Gene Therapies for Cancer Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Gene Induced Immunotherapy
Oncolytic Virotherapy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Gene Therapies for Cancer Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gene Therapies for Cancer Treatment market by identifying its various subsegments.
Focuses on the key global Gene Therapies for Cancer Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Therapies for Cancer Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Gene Therapies for Cancer Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.
Table of Contents
2019-2024 Global Gene Therapies for Cancer Treatment Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapies for Cancer Treatment Market Size 2014-2024
2.1.2 Gene Therapies for Cancer Treatment Market Size CAGR by Region
2.2 Gene Therapies for Cancer Treatment Segment by Type
2.2.1 Gene Induced Immunotherapy
2.2.2 Oncolytic Virotherapy
2.2.3 Gene Transfer
2.3 Gene Therapies for Cancer Treatment Market Size by Type
2.3.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Gene Therapies for Cancer Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gene Therapies for Cancer Treatment Market Size by Application
2.5.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Gene Therapies for Cancer Treatment by Players
3.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Players
3.1.1 Global Gene Therapies for Cancer Treatment Market Size by Players (2017-2019)
3.1.2 Global Gene Therapies for Cancer Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Gene Therapies for Cancer Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Therapies for Cancer Treatment by Regions
4.1 Gene Therapies for Cancer Treatment Market Size by Regions
4.2 Americas Gene Therapies for Cancer Treatment Market Size Growth
4.3 APAC Gene Therapies for Cancer Treatment Market Size Growth
4.4 Europe Gene Therapies for Cancer Treatment Market Size Growth
4.5 Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth
5 Americas
5.1 Americas Gene Therapies for Cancer Treatment Market Size by Countries
5.2 Americas Gene Therapies for Cancer Treatment Market Size by Type
5.3 Americas Gene Therapies for Cancer Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Gene Therapies for Cancer Treatment Market Size by Countries
6.2 APAC Gene Therapies for Cancer Treatment Market Size by Type
6.3 APAC Gene Therapies for Cancer Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Gene Therapies for Cancer Treatment by Countries
7.2 Europe Gene Therapies for Cancer Treatment Market Size by Type
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Gene Therapies for Cancer Treatment by Countries
8.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type
8.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Gene Therapies for Cancer Treatment Market Forecast
10.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)
10.2 Global Gene Therapies for Cancer Treatment Forecast by Regions
10.2.1 Global Gene Therapies for Cancer Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Gene Therapies for Cancer Treatment Forecast by Type
10.8 Global Gene Therapies for Cancer Treatment Forecast by Application
11 Key Players Analysis
11.1 Novartis
11.1.1 Company Details
11.1.2 Gene Therapies for Cancer Treatment Product Offered
11.1.3 Novartis Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Novartis News
11.2 Kite Pharma
11.2.1 Company Details
11.2.2 Gene Therapies for Cancer Treatment Product Offered
11.2.3 Kite Pharma Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Kite Pharma News
11.3 Amgen
11.3.1 Company Details
11.3.2 Gene Therapies for Cancer Treatment Product Offered
11.3.3 Amgen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Amgen News
11.4 Shanghai Sunway
11.4.1 Company Details
11.4.2 Gene Therapies for Cancer Treatment Product Offered
11.4.3 Shanghai Sunway Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Shanghai Sunway News
11.5 Sibiono
11.5.1 Company Details
11.5.2 Gene Therapies for Cancer Treatment Product Offered
11.5.3 Sibiono Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Sibiono News
...
12 Research Findings and Conclusion
*If Applicable.